medicaid glp-1 McKee's proposed FY2027 budget drops drugs for weight loss from • Rhode Island Current 📢 New Resource Alert! We've

Box 1: Recent Trump Administration Obesity Drug Initiatives In November 2025, the Trump administration announced reaching a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1s for Medicare, Medicaid, and those purchasing the drugs directly from the manufacturers through a new TrumpRx website

David Cutler, MD, a board-certified family medicine physician at Providence Saint Johns Health Center in Santa Monica, CA, who was not involved in this study, told MNT that the current economics of supply and demand for GLP-1 medications makes health disparities unavoidable

You will see marketing that implies small, steady doses preserve lean mass

This shifting landscape presents both challenges and opportunities for food manufacturers and suppliers as they adapt to changing consumer interests and emerging functional health priorities

comprises an inordinate proportion of brand name drug revenue and profits because domestic prices are so high

Neuroscience 77 , 257270 (1997)